Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas

Modern Pathology

Volumn 15, Issue 4, 2002, Pages 387-396

  Shukuwa, Tetsuo ^a   Katayama, Ichiro ^a   Koji, Takehiko ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Lymphocytes; Malignant melanoma; Melanocytic nevus; Proliferation

Indexed keywords

CYCLINE; FAS ANTIGEN; FAS LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; NEVUS; NICK END LABELING; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN NEOPLASMS;

EID: 0036230168     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880535     Document Type: Article

References (35)

1. Neoplasia
2. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia
3. Autonomous cell death of mouse male germ cells during fetal and postnatal period
4. Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system
5. Neurodegeneration in Alzheimer disease. Is apoptosis involved?
6. Programmed cell death in the immune system
7. Tumor cells induce apoptosis in lymphocytes
8. Bcl-X and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
9. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis
10. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
11. Detection of DNA strand breaks associated with apoptosis in human brain tumors
12. Cancer statistics 1994
13. Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma
14. Distribution patterns and frequency of proliferating cells in cutaneous keratinocytic neoplasm
15. Apoptosis. A basic biological phenomenon with wide-ranging implications in tissue kinetics
16. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
17. A cell-killing monoclonal antibody (anti-Fas) to cell surface antigen co-downregulated with the receptor of the tumor necrosis factor
18. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis
19. Purification and characterization of the Fas-ligand that induces apoptosis
20. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
21. Melanoma cell expression of Fas(Apo-1/ CD95) ligand: Implications for tumor immune escape
22. Expression of CD95 ligand in melanocytic lesions as a prognostic marker
23. Apoptosis, Fas and Fas-ligand expression in melanocytic tumors
24. Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis
25. Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides
26. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
27. The histogenesis and biological behavior of primary human malignant melanomas of the skin
28. Acral cutaneous melanoma in Caucasians: Clinical features, histopathology and prognosis in 112 patients
29. Heavy metal intensification of DAB-based HRP reaction product
30. Apoptosis and cellular proliferation in human epidermal squamous cell neoplasia
31. Inhibition of growth of melanoma cells by CD95 (Fas/ Apo-1) gene transfer in vivo
32. A comparative study of Fas and Fas-ligand expression during melanoma progression
33. Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients
34. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma
35. The Fas counterattack. Fas-mediated T cell killing by colon cancer cells expressing Fas ligand